BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 26992833)

  • 1. The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.
    Diederichs S; Bartsch L; Berkmann JC; Fröse K; Heitmann J; Hoppe C; Iggena D; Jazmati D; Karschnia P; Linsenmeier M; Maulhardt T; Möhrmann L; Morstein J; Paffenholz SV; Röpenack P; Rückert T; Sandig L; Schell M; Steinmann A; Voss G; Wasmuth J; Weinberger ME; Wullenkord R
    EMBO Mol Med; 2016 May; 8(5):442-57. PubMed ID: 26992833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of driver non-coding splice-site-creating mutations in cancer.
    Cao S; Zhou DC; Oh C; Jayasinghe RG; Zhao Y; Yoon CJ; Wyczalkowski MA; Bailey MH; Tsou T; Gao Q; Malone A; Reynolds S; Shmulevich I; Wendl MC; Chen F; Ding L
    Nat Commun; 2020 Nov; 11(1):5573. PubMed ID: 33149122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNCDatabase: a database of non-coding cancer drivers.
    Liu EM; Martinez-Fundichely A; Bollapragada R; Spiewack M; Khurana E
    Nucleic Acids Res; 2021 Jan; 49(D1):D1094-D1101. PubMed ID: 33095860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synonymous mutations frequently act as driver mutations in human cancers.
    Supek F; Miñana B; Valcárcel J; Gabaldón T; Lehner B
    Cell; 2014 Mar; 156(6):1324-1335. PubMed ID: 24630730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pan-cancer analysis of synonymous mutations.
    Sharma Y; Miladi M; Dukare S; Boulay K; Caudron-Herger M; Groß M; Backofen R; Diederichs S
    Nat Commun; 2019 Jun; 10(1):2569. PubMed ID: 31189880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic synonymous mutations in regulatory elements contribute to the genetic aetiology of melanoma.
    Zhang D; Xia J
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):43. PubMed ID: 32241263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Code inside the codon: The role of synonymous mutations in regulating splicing machinery and its impact on disease.
    Sarkar A; Panati K; Narala VR
    Mutat Res Rev Mutat Res; 2022; 790():108444. PubMed ID: 36307006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway and network analysis of more than 2500 whole cancer genomes.
    Reyna MA; Haan D; Paczkowska M; Verbeke LPC; Vazquez M; Kahraman A; Pulido-Tamayo S; Barenboim J; Wadi L; Dhingra P; Shrestha R; Getz G; Lawrence MS; Pedersen JS; Rubin MA; Wheeler DA; Brunak S; Izarzugaza JMG; Khurana E; Marchal K; von Mering C; Sahinalp SC; Valencia A; ; Reimand J; Stuart JM; Raphael BJ;
    Nat Commun; 2020 Feb; 11(1):729. PubMed ID: 32024854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication.
    Takata MA; Soll SJ; Emery A; Blanco-Melo D; Swanstrom R; Bieniasz PD
    PLoS Pathog; 2018 Jan; 14(1):e1006824. PubMed ID: 29377940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel polymorphisms in UTR and coding region of inducible heat shock protein 70.1 gene in tropically adapted Indian zebu cattle (Bos indicus) and riverine buffalo (Bubalus bubalis).
    Sodhi M; Mukesh M; Kishore A; Mishra BP; Kataria RS; Joshi BK
    Gene; 2013 Sep; 527(2):606-15. PubMed ID: 23792016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.
    Erson-Bensan AE
    Cancer Metastasis Rev; 2020 Sep; 39(3):887-901. PubMed ID: 32361913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer.
    Kitamura K; Nimura K
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of somatic mutations in splicing-associated sequences in cancer genomes.
    Hurst LD; Batada NN
    Genome Biol; 2017 Nov; 18(1):213. PubMed ID: 29115978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Untranslated Regions of mRNAs in Cancer.
    Schuster SL; Hsieh AC
    Trends Cancer; 2019 Apr; 5(4):245-262. PubMed ID: 30961831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The search for cis-regulatory driver mutations in cancer genomes.
    Poulos RC; Sloane MA; Hesson LB; Wong JW
    Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An expanding universe of the non-coding genome in cancer biology.
    Xue B; He L
    Carcinogenesis; 2014 Jun; 35(6):1209-16. PubMed ID: 24747961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the Untranslated Genome and Susceptibility to Infections.
    Ramsuran V; Ewy R; Nguyen H; Kulkarni S
    Front Immunol; 2018; 9():2046. PubMed ID: 30245696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions.
    Aouacheria A; Navratil V; López-Pérez R; Gutiérrez NC; Churkin A; Barash D; Mouchiroud D; Gautier C
    BMC Genomics; 2007 Jan; 8():2. PubMed ID: 17201911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide view of miniature inverted-repeat transposable elements (MITEs) in rice, Oryza sativa ssp. japonica.
    Oki N; Yano K; Okumoto Y; Tsukiyama T; Teraishi M; Tanisaka T
    Genes Genet Syst; 2008 Aug; 83(4):321-9. PubMed ID: 18931457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
    Rush M; Zhao X; Schwartz S
    J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.